APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Obesity Diagnosis and Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Obesity Diagnosis and Treatment Industry Growth and Trends Forecast to 2032

Report ID 17419962013 May 2026123 pages

Choose your research edition.

Industry ResearchObesity Diagnosis and Treatment Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Obesity Diagnosis and Treatment Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Obesity Diagnosis and Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Obesity Diagnosis and Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Obesity Diagnosis and Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

According to APO Research, the global Obesity Diagnosis and Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Obesity Diagnosis and Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Obesity Diagnosis and Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Obesity Diagnosis and Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Obesity Diagnosis and Treatment market include Obesity diagnosis and treatment, GlaxoSmithKline, Arena Pharmaceuticals, Pfizer, Allergan, Obalon Therapeutics, Nalpropion Pharmaceuticals, Novo Nordisk and Beijing Noble Laser Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Obesity Diagnosis and Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Obesity Diagnosis and Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Obesity Diagnosis and Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Obesity Diagnosis and Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Obesity Diagnosis and Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Obesity Diagnosis and Treatment Market by Company

Obesity diagnosis and treatment

GlaxoSmithKline

Arena Pharmaceuticals

Pfizer

Allergan

Obalon Therapeutics

Nalpropion Pharmaceuticals

Novo Nordisk

Beijing Noble Laser Technology

Eisai

Orexigen Therapeutics

ReShape Lifesciences

Roche

Allurion Technologies

Medtronic

VIVUS

ApolloEndosurgery

Ethicon, Inc.

AstraZeneca

Takeda Pharmaceutical Company

Currax Pharmaceuticals

Obesity Diagnosis and Treatment Segment by Type

Medication

Surgery

Fitness

Others

Obesity Diagnosis and Treatment Segment by Application

<18 Years Old

18-35 Years Old

36-45 Years Old

45-55 Years Old

>55 Years Old

Obesity Diagnosis and Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obesity Diagnosis and Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Obesity Diagnosis and Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obesity Diagnosis and Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Obesity Diagnosis and Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Obesity Diagnosis and Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Obesity Diagnosis and Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Obesity Diagnosis and Treatment Market Share by Region (2021-2026) Table 4. Global Obesity Diagnosis and Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Obesity Diagnosis and Treatment Market Share by Region (2027-2032) Table 6. Global Obesity Diagnosis and Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Obesity Diagnosis and Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Obesity Diagnosis and Treatment Market Size Share by Type (2021-2026) Table 9. Global Obesity Diagnosis and Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Obesity Diagnosis and Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Obesity Diagnosis and Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Obesity Diagnosis and Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Obesity Diagnosis and Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Obesity Diagnosis and Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Obesity Diagnosis and Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Obesity Diagnosis and Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Obesity Diagnosis and Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Obesity Diagnosis and Treatment Market Size Share by Application (2021-2026) Table 24. Global Obesity Diagnosis and Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Obesity Diagnosis and Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Obesity Diagnosis and Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Obesity Diagnosis and Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Obesity Diagnosis and Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Obesity Diagnosis and Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Obesity Diagnosis and Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Obesity Diagnosis and Treatment Industry Trends Table 37. Obesity Diagnosis and Treatment Industry Drivers Table 38. Obesity Diagnosis and Treatment Industry Opportunities and Challenges Table 39. Obesity Diagnosis and Treatment Industry Restraints Table 40. Global Obesity Diagnosis and Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Obesity Diagnosis and Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Obesity Diagnosis and Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Obesity Diagnosis and Treatment Key Company Headquarters & Area Served Table 44. Global Obesity Diagnosis and Treatment Company, Product Type & Application Table 45. Global Obesity Diagnosis and Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Obesity Diagnosis and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Obesity diagnosis and treatment Company Information Table 49. Obesity diagnosis and treatment Business Overview Table 50. Obesity diagnosis and treatment Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Obesity diagnosis and treatment Obesity Diagnosis and Treatment Product Portfolio Table 52. Obesity diagnosis and treatment Recent Development Table 53. GlaxoSmithKline Company Information Table 54. GlaxoSmithKline Business Overview Table 55. GlaxoSmithKline Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. GlaxoSmithKline Obesity Diagnosis and Treatment Product Portfolio Table 57. GlaxoSmithKline Recent Development Table 58. Arena Pharmaceuticals Company Information Table 59. Arena Pharmaceuticals Business Overview Table 60. Arena Pharmaceuticals Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Arena Pharmaceuticals Obesity Diagnosis and Treatment Product Portfolio Table 62. Arena Pharmaceuticals Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Obesity Diagnosis and Treatment Product Portfolio Table 67. Pfizer Recent Development Table 68. Allergan Company Information Table 69. Allergan Business Overview Table 70. Allergan Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Allergan Obesity Diagnosis and Treatment Product Portfolio Table 72. Allergan Recent Development Table 73. Obalon Therapeutics Company Information Table 74. Obalon Therapeutics Business Overview Table 75. Obalon Therapeutics Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Obalon Therapeutics Obesity Diagnosis and Treatment Product Portfolio Table 77. Obalon Therapeutics Recent Development Table 78. Nalpropion Pharmaceuticals Company Information Table 79. Nalpropion Pharmaceuticals Business Overview Table 80. Nalpropion Pharmaceuticals Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Nalpropion Pharmaceuticals Obesity Diagnosis and Treatment Product Portfolio Table 82. Nalpropion Pharmaceuticals Recent Development Table 83. Novo Nordisk Company Information Table 84. Novo Nordisk Business Overview Table 85. Novo Nordisk Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Novo Nordisk Obesity Diagnosis and Treatment Product Portfolio Table 87. Novo Nordisk Recent Development Table 88. Beijing Noble Laser Technology Company Information Table 89. Beijing Noble Laser Technology Business Overview Table 90. Beijing Noble Laser Technology Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Beijing Noble Laser Technology Obesity Diagnosis and Treatment Product Portfolio Table 92. Beijing Noble Laser Technology Recent Development Table 93. Eisai Company Information Table 94. Eisai Business Overview Table 95. Eisai Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eisai Obesity Diagnosis and Treatment Product Portfolio Table 97. Eisai Recent Development Table 98. Orexigen Therapeutics Company Information Table 99. Orexigen Therapeutics Business Overview Table 100. Orexigen Therapeutics Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Orexigen Therapeutics Obesity Diagnosis and Treatment Product Portfolio Table 102. Orexigen Therapeutics Recent Development Table 103. ReShape Lifesciences Company Information Table 104. ReShape Lifesciences Business Overview Table 105. ReShape Lifesciences Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. ReShape Lifesciences Obesity Diagnosis and Treatment Product Portfolio Table 107. ReShape Lifesciences Recent Development Table 108. Roche Company Information Table 109. Roche Business Overview Table 110. Roche Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Roche Obesity Diagnosis and Treatment Product Portfolio Table 112. Roche Recent Development Table 113. Allurion Technologies Company Information Table 114. Allurion Technologies Business Overview Table 115. Allurion Technologies Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Allurion Technologies Obesity Diagnosis and Treatment Product Portfolio Table 117. Allurion Technologies Recent Development Table 118. Medtronic Company Information Table 119. Medtronic Business Overview Table 120. Medtronic Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Medtronic Obesity Diagnosis and Treatment Product Portfolio Table 122. Medtronic Recent Development Table 123. VIVUS Company Information Table 124. VIVUS Business Overview Table 125. VIVUS Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. VIVUS Obesity Diagnosis and Treatment Product Portfolio Table 127. VIVUS Recent Development Table 128. ApolloEndosurgery Company Information Table 129. ApolloEndosurgery Business Overview Table 130. ApolloEndosurgery Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. ApolloEndosurgery Obesity Diagnosis and Treatment Product Portfolio Table 132. ApolloEndosurgery Recent Development Table 133. Ethicon, Inc. Company Information Table 134. Ethicon, Inc. Business Overview Table 135. Ethicon, Inc. Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Ethicon, Inc. Obesity Diagnosis and Treatment Product Portfolio Table 137. Ethicon, Inc. Recent Development Table 138. AstraZeneca Company Information Table 139. AstraZeneca Business Overview Table 140. AstraZeneca Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. AstraZeneca Obesity Diagnosis and Treatment Product Portfolio Table 142. AstraZeneca Recent Development Table 143. Takeda Pharmaceutical Company Company Information Table 144. Takeda Pharmaceutical Company Business Overview Table 145. Takeda Pharmaceutical Company Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Takeda Pharmaceutical Company Obesity Diagnosis and Treatment Product Portfolio Table 147. Takeda Pharmaceutical Company Recent Development Table 148. Currax Pharmaceuticals Company Information Table 149. Currax Pharmaceuticals Business Overview Table 150. Currax Pharmaceuticals Obesity Diagnosis and Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Currax Pharmaceuticals Obesity Diagnosis and Treatment Product Portfolio Table 152. Currax Pharmaceuticals Recent Development Table 153. North America Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Obesity Diagnosis and Treatment Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Obesity Diagnosis and Treatment Market Share by Country (2021-2026) Table 156. North America Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Obesity Diagnosis and Treatment Market Share Forecast by Country (2027-2032) Table 158. Europe Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Obesity Diagnosis and Treatment Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Obesity Diagnosis and Treatment Market Share by Country (2021-2026) Table 161. Europe Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Obesity Diagnosis and Treatment Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Obesity Diagnosis and Treatment Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Obesity Diagnosis and Treatment Market Share by Country (2021-2026) Table 166. Asia-Pacific Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Obesity Diagnosis and Treatment Market Share Forecast by Country (2027-2032) Table 168. Latin America Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Obesity Diagnosis and Treatment Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Obesity Diagnosis and Treatment Market Share by Country (2021-2026) Table 171. Latin America Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Obesity Diagnosis and Treatment Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Obesity Diagnosis and Treatment Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Obesity Diagnosis and Treatment Market Share by Country (2021-2026) Table 176. Middle East & Africa Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Obesity Diagnosis and Treatment Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Obesity Diagnosis and Treatment Product Image Figure 3. Global Obesity Diagnosis and Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Obesity Diagnosis and Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Obesity Diagnosis and Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Obesity Diagnosis and Treatment Market Share by Region (2021-2032) Figure 7. North America Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Medication Image Figure 13. Global Medication Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Surgery Image Figure 15. Global Surgery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Fitness Image Figure 17. Global Fitness Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Obesity Diagnosis and Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Obesity Diagnosis and Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Obesity Diagnosis and Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Obesity Diagnosis and Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Obesity Diagnosis and Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Obesity Diagnosis and Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Obesity Diagnosis and Treatment Market Size Share by Type (2021-2032) Figure 27. <18 Years Old Image Figure 28. Global <18 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. 18-35 Years Old Image Figure 30. Global 18-35 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. 36-45 Years Old Image Figure 32. Global 36-45 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. 45-55 Years Old Image Figure 34. Global 45-55 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. >55 Years Old Image Figure 36. Global >55 Years Old Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Obesity Diagnosis and Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Obesity Diagnosis and Treatment Market Share by Application 2025 VS 2032 Figure 39. North America Obesity Diagnosis and Treatment Market Size Share by Application (2021-2032) Figure 40. Europe Obesity Diagnosis and Treatment Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Obesity Diagnosis and Treatment Market Size Share by Application (2021-2032) Figure 42. Latin America Obesity Diagnosis and Treatment Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Obesity Diagnosis and Treatment Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Obesity Diagnosis and Treatment Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Obesity Diagnosis and Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Obesity Diagnosis and Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Obesity Diagnosis and Treatment Market Share by Country (2021-2032) Figure 49. Europe Obesity Diagnosis and Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Obesity Diagnosis and Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Obesity Diagnosis and Treatment Market Share by Country (2021-2032) Figure 52. Asia-Pacific Obesity Diagnosis and Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Obesity Diagnosis and Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Obesity Diagnosis and Treatment Market Share by Country (2021-2032) Figure 55. Latin America Obesity Diagnosis and Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Obesity Diagnosis and Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Obesity Diagnosis and Treatment Market Share by Country (2021-2032) Figure 58. Middle East & Africa Obesity Diagnosis and Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Obesity Diagnosis and Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Obesity Diagnosis and Treatment Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Medication
  • Surgery
  • Fitness
  • Others
Applications
  • <18 Years Old
  • 18-35 Years Old
  • 36-45 Years Old
  • 45-55 Years Old
  • >55 Years Old
Companies covered
  • Obesity diagnosis and treatment
  • GlaxoSmithKline
  • Arena Pharmaceuticals
  • Pfizer
  • Allergan
  • Obalon Therapeutics
  • Nalpropion Pharmaceuticals
  • Novo Nordisk
  • Beijing Noble Laser Technology
  • Eisai
  • Orexigen Therapeutics
  • ReShape Lifesciences
  • Roche
  • Allurion Technologies
  • Medtronic
  • VIVUS
  • ApolloEndosurgery
  • Ethicon, Inc.
  • AstraZeneca
  • Takeda Pharmaceutical Company
  • Currax Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Obesity Diagnosis and Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Obesity Diagnosis and Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Obesity Diagnosis and Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Obesity Diagnosis and Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Obesity Diagnosis and Treatment Market Size (2021-2032)
  8. 1.5.1 North America Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Obesity Diagnosis and Treatment Market Size Growth Rate (2021-2032)
2 Obesity Diagnosis and Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Medication
  3. 2.1.2 Surgery
  4. 2.1.3 Fitness
  5. 2.1.4 Others
  6. 2.2 Global Obesity Diagnosis and Treatment Market Size by Type
  7. 2.2.1 Global Obesity Diagnosis and Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Obesity Diagnosis and Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Obesity Diagnosis and Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Obesity Diagnosis and Treatment Market Size by Regions
  11. 2.3.1 North America Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Obesity Diagnosis and Treatment Market Size Breakdown by Type (2021-2026)
3 Obesity Diagnosis and Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 <18 Years Old
  3. 3.1.2 18-35 Years Old
  4. 3.1.3 36-45 Years Old
  5. 3.1.4 45-55 Years Old
  6. 3.1.5 >55 Years Old
  7. 3.2 Global Obesity Diagnosis and Treatment Market Size by Application
  8. 3.2.1 Global Obesity Diagnosis and Treatment Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Obesity Diagnosis and Treatment Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Obesity Diagnosis and Treatment Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Obesity Diagnosis and Treatment Market Size by Regions
  12. 3.3.1 North America Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Obesity Diagnosis and Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Obesity Diagnosis and Treatment Industry Trends
  2. 4.2 Obesity Diagnosis and Treatment Industry Drivers
  3. 4.3 Obesity Diagnosis and Treatment Industry Opportunities and Challenges
  4. 4.4 Obesity Diagnosis and Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Obesity Diagnosis and Treatment Revenue (2021-2026)
  2. 5.2 Global Obesity Diagnosis and Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Obesity Diagnosis and Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Obesity Diagnosis and Treatment Company, Product Type & Application
  5. 5.5 Global Obesity Diagnosis and Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Obesity Diagnosis and Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Obesity Diagnosis and Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Obesity Diagnosis and Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Obesity diagnosis and treatment
  2. 6.1.1 Obesity diagnosis and treatment Company Information
  3. 6.1.2 Obesity diagnosis and treatment Business Overview
  4. 6.1.3 Obesity diagnosis and treatment Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Obesity diagnosis and treatment Obesity Diagnosis and Treatment Product Portfolio
  6. 6.1.5 Obesity diagnosis and treatment Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Obesity Diagnosis and Treatment Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Arena Pharmaceuticals
  14. 6.3.1 Arena Pharmaceuticals Company Information
  15. 6.3.2 Arena Pharmaceuticals Business Overview
  16. 6.3.3 Arena Pharmaceuticals Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Arena Pharmaceuticals Obesity Diagnosis and Treatment Product Portfolio
  18. 6.3.5 Arena Pharmaceuticals Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Obesity Diagnosis and Treatment Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Allergan
  26. 6.5.1 Allergan Company Information
  27. 6.5.2 Allergan Business Overview
  28. 6.5.3 Allergan Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Allergan Obesity Diagnosis and Treatment Product Portfolio
  30. 6.5.5 Allergan Recent Developments
  31. 6.6 Obalon Therapeutics
  32. 6.6.1 Obalon Therapeutics Company Information
  33. 6.6.2 Obalon Therapeutics Business Overview
  34. 6.6.3 Obalon Therapeutics Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Obalon Therapeutics Obesity Diagnosis and Treatment Product Portfolio
  36. 6.6.5 Obalon Therapeutics Recent Developments
  37. 6.7 Nalpropion Pharmaceuticals
  38. 6.7.1 Nalpropion Pharmaceuticals Company Information
  39. 6.7.2 Nalpropion Pharmaceuticals Business Overview
  40. 6.7.3 Nalpropion Pharmaceuticals Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Nalpropion Pharmaceuticals Obesity Diagnosis and Treatment Product Portfolio
  42. 6.7.5 Nalpropion Pharmaceuticals Recent Developments
  43. 6.8 Novo Nordisk
  44. 6.8.1 Novo Nordisk Company Information
  45. 6.8.2 Novo Nordisk Business Overview
  46. 6.8.3 Novo Nordisk Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Novo Nordisk Obesity Diagnosis and Treatment Product Portfolio
  48. 6.8.5 Novo Nordisk Recent Developments
  49. 6.9 Beijing Noble Laser Technology
  50. 6.9.1 Beijing Noble Laser Technology Company Information
  51. 6.9.2 Beijing Noble Laser Technology Business Overview
  52. 6.9.3 Beijing Noble Laser Technology Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Beijing Noble Laser Technology Obesity Diagnosis and Treatment Product Portfolio
  54. 6.9.5 Beijing Noble Laser Technology Recent Developments
  55. 6.10 Eisai
  56. 6.10.1 Eisai Company Information
  57. 6.10.2 Eisai Business Overview
  58. 6.10.3 Eisai Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eisai Obesity Diagnosis and Treatment Product Portfolio
  60. 6.10.5 Eisai Recent Developments
  61. 6.11 Orexigen Therapeutics
  62. 6.11.1 Orexigen Therapeutics Company Information
  63. 6.11.2 Orexigen Therapeutics Business Overview
  64. 6.11.3 Orexigen Therapeutics Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Orexigen Therapeutics Obesity Diagnosis and Treatment Product Portfolio
  66. 6.11.5 Orexigen Therapeutics Recent Developments
  67. 6.12 ReShape Lifesciences
  68. 6.12.1 ReShape Lifesciences Company Information
  69. 6.12.2 ReShape Lifesciences Business Overview
  70. 6.12.3 ReShape Lifesciences Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 ReShape Lifesciences Obesity Diagnosis and Treatment Product Portfolio
  72. 6.12.5 ReShape Lifesciences Recent Developments
  73. 6.13 Roche
  74. 6.13.1 Roche Company Information
  75. 6.13.2 Roche Business Overview
  76. 6.13.3 Roche Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Roche Obesity Diagnosis and Treatment Product Portfolio
  78. 6.13.5 Roche Recent Developments
  79. 6.14 Allurion Technologies
  80. 6.14.1 Allurion Technologies Company Information
  81. 6.14.2 Allurion Technologies Business Overview
  82. 6.14.3 Allurion Technologies Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Allurion Technologies Obesity Diagnosis and Treatment Product Portfolio
  84. 6.14.5 Allurion Technologies Recent Developments
  85. 6.15 Medtronic
  86. 6.15.1 Medtronic Company Information
  87. 6.15.2 Medtronic Business Overview
  88. 6.15.3 Medtronic Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Medtronic Obesity Diagnosis and Treatment Product Portfolio
  90. 6.15.5 Medtronic Recent Developments
  91. 6.16 VIVUS
  92. 6.16.1 VIVUS Company Information
  93. 6.16.2 VIVUS Business Overview
  94. 6.16.3 VIVUS Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 VIVUS Obesity Diagnosis and Treatment Product Portfolio
  96. 6.16.5 VIVUS Recent Developments
  97. 6.17 ApolloEndosurgery
  98. 6.17.1 ApolloEndosurgery Company Information
  99. 6.17.2 ApolloEndosurgery Business Overview
  100. 6.17.3 ApolloEndosurgery Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 ApolloEndosurgery Obesity Diagnosis and Treatment Product Portfolio
  102. 6.17.5 ApolloEndosurgery Recent Developments
  103. 6.18 Ethicon, Inc.
  104. 6.18.1 Ethicon, Inc. Company Information
  105. 6.18.2 Ethicon, Inc. Business Overview
  106. 6.18.3 Ethicon, Inc. Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Ethicon, Inc. Obesity Diagnosis and Treatment Product Portfolio
  108. 6.18.5 Ethicon, Inc. Recent Developments
  109. 6.19 AstraZeneca
  110. 6.19.1 AstraZeneca Company Information
  111. 6.19.2 AstraZeneca Business Overview
  112. 6.19.3 AstraZeneca Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 AstraZeneca Obesity Diagnosis and Treatment Product Portfolio
  114. 6.19.5 AstraZeneca Recent Developments
  115. 6.20 Takeda Pharmaceutical Company
  116. 6.20.1 Takeda Pharmaceutical Company Company Information
  117. 6.20.2 Takeda Pharmaceutical Company Business Overview
  118. 6.20.3 Takeda Pharmaceutical Company Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Takeda Pharmaceutical Company Obesity Diagnosis and Treatment Product Portfolio
  120. 6.20.5 Takeda Pharmaceutical Company Recent Developments
  121. 6.21 Currax Pharmaceuticals
  122. 6.21.1 Currax Pharmaceuticals Company Information
  123. 6.21.2 Currax Pharmaceuticals Business Overview
  124. 6.21.3 Currax Pharmaceuticals Obesity Diagnosis and Treatment Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Currax Pharmaceuticals Obesity Diagnosis and Treatment Product Portfolio
  126. 6.21.5 Currax Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Obesity Diagnosis and Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Obesity Diagnosis and Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Obesity Diagnosis and Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Obesity Diagnosis and Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Obesity Diagnosis and Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Obesity Diagnosis and Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Obesity Diagnosis and Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst